DK8080A - Fremgangsmaade til fremstilling af en graneleret formulering af nabilon - Google Patents
Fremgangsmaade til fremstilling af en graneleret formulering af nabilonInfo
- Publication number
- DK8080A DK8080A DK8080A DK8080A DK8080A DK 8080 A DK8080 A DK 8080A DK 8080 A DK8080 A DK 8080A DK 8080 A DK8080 A DK 8080A DK 8080 A DK8080 A DK 8080A
- Authority
- DK
- Denmark
- Prior art keywords
- graneled
- nabilon
- formulation
- preparing
- procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/019,810 US4195078A (en) | 1979-03-09 | 1979-03-09 | Nabilone granulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK8080A true DK8080A (da) | 1980-09-10 |
Family
ID=21795156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK8080A DK8080A (da) | 1979-03-09 | 1980-01-08 | Fremgangsmaade til fremstilling af en graneleret formulering af nabilon |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4195078A (da) |
| EP (1) | EP0015635A1 (da) |
| JP (1) | JPS55133309A (da) |
| AU (1) | AU531805B2 (da) |
| BE (1) | BE881049A (da) |
| CA (1) | CA1124178A (da) |
| CH (1) | CH643840A5 (da) |
| DK (1) | DK8080A (da) |
| FR (1) | FR2450606A1 (da) |
| GB (1) | GB2045080B (da) |
| IE (1) | IE49243B1 (da) |
| IL (1) | IL59098A (da) |
| IT (1) | IT1193886B (da) |
| LU (1) | LU82072A1 (da) |
| NZ (1) | NZ192557A (da) |
| ZA (1) | ZA80104B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327080A (en) * | 1981-07-13 | 1982-04-27 | E. R. Squibb & Sons, Inc. | Novel Bendroflumethiazide formulations and method |
| JPS59155309A (ja) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | 活性型ビタミンｄ↓３類組成物 |
| NZ211545A (en) * | 1984-04-11 | 1987-09-30 | Ici Australia Ltd | Composition having particulate trace element suspended in matrix of solid polyethylene glycol |
| US4790991A (en) * | 1985-02-05 | 1988-12-13 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
| US4818539A (en) * | 1985-02-05 | 1989-04-04 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
| US4851392A (en) * | 1985-02-05 | 1989-07-25 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
| US4747881A (en) * | 1985-02-05 | 1988-05-31 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
| US4843098A (en) * | 1985-02-05 | 1989-06-27 | Warner-Lambert Company | Ingestible aggregate and delivery system prepared therefrom |
| US4844908A (en) * | 1986-11-27 | 1989-07-04 | Duphar International Research B.V. | Method of preparing tablets with clovoxamine fumarate and tablets thus prepared |
| EP0547796A1 (en) * | 1991-12-17 | 1993-06-23 | Konica Corporation | Solid chemicals for processing silver halide photographic light-sensitive material |
| US6566560B2 (en) | 1999-03-22 | 2003-05-20 | Immugen Pharmaceuticals, Inc. | Resorcinolic compounds |
| US20020137802A1 (en) * | 2000-09-28 | 2002-09-26 | Travis Craig R. | Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation |
| US6541510B2 (en) * | 2000-09-28 | 2003-04-01 | Immugen Pharmaceuticals, Inc. | Antiviral methods and compounds |
| US20030232101A1 (en) * | 2002-03-18 | 2003-12-18 | Immugen Pharmaceuticals, Inc. | Topical formulations of resorcinols and cannibinoids and methods of use |
| CA2845443A1 (en) * | 2014-03-04 | 2015-09-04 | Pharmascience Inc. | Orally disintegrating tablet of nabilone and method of manufacturing |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR886435A (fr) * | 1941-09-29 | 1943-10-14 | Aiguille à tricoter perfectionnée | |
| US3136692A (en) * | 1961-06-30 | 1964-06-09 | Strong Cobb Arner Inc | Effervescent composition containing polyvinylpyrrolidone |
| DE1467792A1 (de) * | 1965-05-21 | 1968-12-12 | Brunnengraeber & Co Gmbh Dr Ch | Sprengmittel fuer pharmazeutische Presslinge |
| CA885974A (en) * | 1968-04-02 | 1971-11-16 | R. Telfer William | Ferrous fumarate capsule and preparation |
| IL32673A (en) * | 1968-08-05 | 1973-11-28 | Ciba Geigy Ag | A granular material containing oily or liquid therapeutically usable furanosides and a process for its manufacture |
| US3632778A (en) * | 1970-06-10 | 1972-01-04 | Hoffmann La Roche | Tablets containing l-dopa |
| NL7112288A (da) * | 1970-09-16 | 1972-03-20 | ||
| JPS5418330B2 (da) * | 1973-03-16 | 1979-07-06 | ||
| US3851032A (en) * | 1973-04-23 | 1974-11-26 | Sterling Drug Inc | Process of preparing a solid fine crystalline paracetamol polymer complex composition |
| US3864492A (en) * | 1973-08-01 | 1975-02-04 | Abbott Lab | Method of treating depression using 1,4{40 -dihydroxy-3-n-pentyl-6,6,9-trimethyl-6a,7,10,10a-tetra-hydrodibenzo{8 b,d{9 pyran |
| US3920809A (en) * | 1973-11-05 | 1975-11-18 | Lilly Co Eli | Dibenzo(b,d)pyranone dispersions |
| US3987188A (en) * | 1973-11-05 | 1976-10-19 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as sedative drugs |
| US3953603A (en) * | 1973-11-05 | 1976-04-27 | Eli Lilly And Company | Hexahydro-dibenzo[b,d,]pyran-9-ones as psychotropic, particularly anti-depressant drugs |
| US3944673A (en) * | 1973-11-05 | 1976-03-16 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs |
| US4024275A (en) * | 1973-11-05 | 1977-05-17 | Eli Lilly And Company | Method of reducing elevated blood pressure with dihydroxy-hexahydrodibenzo(b,d)pyrans |
| IE39678B1 (en) * | 1973-11-05 | 1978-12-06 | Lilly Co Eli | A polymorphic form of a dibenzopyranone |
| AT329556B (de) * | 1974-10-24 | 1976-05-25 | Lilly Co Eli | Verfahren zur herstellung einer neuen stabilen polymorphen kristallinen form von 1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-on |
| US4143129A (en) * | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
| US4087545A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs |
| US4088777A (en) * | 1976-02-17 | 1978-05-09 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as anticonvulsant drugs |
| US4087547A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones in treatment of glaucoma |
| US4087546A (en) * | 1976-02-17 | 1978-05-02 | Eli Lilly And Company | Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs |
-
1979
- 1979-03-09 US US06/019,810 patent/US4195078A/en not_active Expired - Lifetime
-
1980
- 1980-01-08 DK DK8080A patent/DK8080A/da not_active Application Discontinuation
- 1980-01-08 ZA ZA00800104A patent/ZA80104B/xx unknown
- 1980-01-08 NZ NZ192557A patent/NZ192557A/xx unknown
- 1980-01-08 CA CA343,252A patent/CA1124178A/en not_active Expired
- 1980-01-09 BE BE1/9675A patent/BE881049A/fr not_active IP Right Cessation
- 1980-01-09 IT IT19114/80A patent/IT1193886B/it active
- 1980-01-09 CH CH13880A patent/CH643840A5/fr not_active IP Right Cessation
- 1980-01-09 FR FR8000430A patent/FR2450606A1/fr active Granted
- 1980-01-09 IL IL59098A patent/IL59098A/xx not_active IP Right Cessation
- 1980-01-10 LU LU82072A patent/LU82072A1/fr unknown
- 1980-01-10 EP EP80300094A patent/EP0015635A1/en not_active Ceased
- 1980-01-10 JP JP172880A patent/JPS55133309A/ja active Granted
- 1980-01-10 IE IE42/80A patent/IE49243B1/en not_active IP Right Cessation
- 1980-01-10 GB GB8000871A patent/GB2045080B/en not_active Expired
- 1980-01-11 AU AU54554/80A patent/AU531805B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| BE881049A (fr) | 1980-07-09 |
| GB2045080A (en) | 1980-10-29 |
| IL59098A0 (en) | 1980-05-30 |
| FR2450606B1 (da) | 1983-04-15 |
| IE800042L (en) | 1980-09-09 |
| ZA80104B (en) | 1981-08-26 |
| IE49243B1 (en) | 1985-09-04 |
| CA1124178A (en) | 1982-05-25 |
| CH643840A5 (fr) | 1984-06-29 |
| GB2045080B (en) | 1983-05-25 |
| FR2450606A1 (fr) | 1980-10-03 |
| AU531805B2 (en) | 1983-09-08 |
| US4195078A (en) | 1980-03-25 |
| IT1193886B (it) | 1988-08-31 |
| AU5455480A (en) | 1980-09-11 |
| JPS55133309A (en) | 1980-10-17 |
| JPH0142923B2 (da) | 1989-09-18 |
| EP0015635A1 (en) | 1980-09-17 |
| LU82072A1 (fr) | 1980-04-23 |
| IT8019114A0 (it) | 1980-01-09 |
| NZ192557A (en) | 1981-05-01 |
| IL59098A (en) | 1983-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK363179A (da) | Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
| DK457779A (da) | Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater | |
| DK29681A (da) | Fremgangsmaade til fremstilling af immunogammaglobulin | |
| DK311580A (da) | Fremgangsmaade til fremstilling af oxoalkylxanthiner | |
| DK488379A (da) | Fremgangsmaade til fremstilling af polyetherderivater | |
| DK294880A (da) | Fremgangsmaade til fremstilling af n-phosphonomethylglycin | |
| DK274580A (da) | Fremgangsmaade til fremstilling af tripeptidamider | |
| DK149623C (da) | Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider | |
| DK153791C (da) | Fremgangsmaade til fremstilling af 7-hydroxycumaraner | |
| DK8080A (da) | Fremgangsmaade til fremstilling af en graneleret formulering af nabilon | |
| DK413780A (da) | Fremgangsmaade til fremstilling af d-6-n-propylergoliner | |
| DK138879A (da) | Fremgangsmaade til fremstilling af lysergolderivater | |
| DK262180A (da) | Fremgangsmaade til fremstilling af alkyl-2-chlorpropionater | |
| DK7679A (da) | Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat | |
| DK274680A (da) | Fremgangsmaade til fremstilling af tripeptidamider | |
| DK177680A (da) | Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner | |
| DK157850C (da) | Fremgangsmaade til fremstilling af 7-acylindolin-2-oner | |
| DK318280A (da) | Fremgangsmaade til fremstilling af naphthyridinderivater | |
| DK183780A (da) | Femgangsmaade til fremstilling af hydroxyderivater af isopropylaminopyrimidin | |
| DK392879A (da) | Fremgangsmaade til fremstilling af 3-karbamouloxymetylcephalosorinforbindelser | |
| DK156427C (da) | Fremgangsmaade til fremstilling af n-alkylarylaminer | |
| DK89280A (da) | Fremgangsmaade til fremstilling af et carbazolderivat | |
| DK457680A (da) | Fremgangsmaade til fremstilling af et urinstofderivat | |
| DK12879A (da) | R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate | |
| DK154880A (da) | Fremgangsmaade til fremstilling af derivater af 6beta-amidinopenicillansyre |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |